Lise Lotte Gluud

机构：University of Copenhagen, Amager Hospital, Hvidovre Hospital, Copenhagen University Hospital · ORCID：0000-0002-9462-4468

发表论文 483 篇 · 总被引 32532 次 · h-index 76

代表论文

• Modulation of metabolic, inflammatory and fibrotic pathways by semaglutide in metabolic dysfunction-associated steatohepatitis (2025 · Nature Medicine · 被引 100)
• Genome-wide meta-analysis identifies nine loci associated with higher risk of hepatocellular carcinoma development (2025 · JHEP Reports · 被引 14)
• Cardiovascular implications of MASLD: overview of the evidence (2025 · Scandinavian Journal of Gastroenterology · 被引 6)
• Alterations in one-carbon metabolism in metabolic dysfunction associated steatotic liver disease may be modified by semaglutide (2025 · Annals of Hepatology · 被引 5)
• Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to metabolic dysfunction-associated steatohepatitis: a phase 2, dose-ranging, double-blind, randomised controlled trial (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 3)
• Glucagon increases plasma levels of cyclic AMP responses in mice and humans, and this may be independent of MASLD (2025 · American Journal of Physiology-Endocrinology and Metabolism · 被引 3)